Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
How to take Ritlecitinib correctlyAlways take Ritlecitinib exactly as directed by your doctor. The recommended dose is 50 mg once daily, taken orally. Swallow the capsule whole wit···【more】
Article source：Captain MedicineRelease date：2026-05-18Recommended：48
When should Ritlecitinib NOT be used?Before starting treatment with Ritlecitinib, the following conditions must be ruled out: you are absolutely prohibited from using Ritlecitinib ···【more】
Article source：Captain MedicineRelease date：2026-05-18Recommended：34
Mechanism of Action and Use of RitlecitinibRitlecitinib is a hard capsule containing 50 mg of the active substance ritlecitinib per capsule. This medicine is used to treat severe a···【more】
Article source：Captain MedicineRelease date：2026-05-18Recommended：36
Possible Side Effects of Tirzepatide and How to Manage ThemSerious Side Effects (Uncommon to Rare):Acute pancreatitis (incidence ≤1/100), presenting as persistent severe abdominal ···【more】
Article source：Captain MedicineRelease date：2026-05-15Recommended：49
How to determine the correct dosage of Tirzepatide?Adult initiation regimen: The initial dose is 2.5 mg once weekly for 4 consecutive weeks. After that, the doctor will increase th···【more】
Article source：Captain MedicineRelease date：2026-05-15Recommended：52
Who should not use Tirzepatide?Tirzepatide is contraindicated in patients who are allergic to tirzepatide or any of its excipients (excipients include disodium hydrogen phosphate h···【more】
Article source：Captain MedicineRelease date：2026-05-15Recommended：42
What is Tirzepatide?Tirzepatide contains the active substance tirzepatide. It is a clear, colourless to light yellow solution for subcutaneous injection. There are six strengths: 2···【more】
Article source：Captain MedicineRelease date：2026-05-15Recommended：46
Storage Conditions and Expiry Date of RitlecitinibAlways store ritlecitinib in a place where children cannot see or reach it to avoid accidental ingestion. Do not use the medicine ···【more】
Article source：Captain MedicineRelease date：2026-05-14Recommended：43
Standard Dosage and Administration of RitlecitinibAlways follow your doctor's instructions when taking ritlecitinib. The recommended dose is 50 mg (one capsule) once daily, tak···【more】
Article source：Captain MedicineRelease date：2026-05-14Recommended：49
Ritlecitinib: Infection Risks to Be Aware OfBefore and during treatment with ritlecitinib, you must contact your doctor immediately if you experience any signs of infection, such a···【more】
Article source：Captain MedicineRelease date：2026-05-14Recommended：48
Uses of RitlecitinibThe core active ingredient of Ritlecitinib is ritlecitinib. It is used to treat severe alopecia areata in adults and adolescents aged 12 years and older. Alopec···【more】
Article source：Captain MedicineRelease date：2026-05-14Recommended：47
Possible side effects of Palbociclib and their frequencyLike all anticancer drugs, Palbociclib can cause side effects, but not everyone experiences them. Very common side effects (···【more】
Article source：Captain MedicineRelease date：2026-05-13Recommended：46
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：3512025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5522024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3372025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3522025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3272025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3932025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3262025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：3012025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
